Detail akcie Takeda Pharm online

Business Summary: Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric diseases), as well as two business units of plasma fractionation products and vaccines. The Company is engaged in the improvement of pipelines at research and development centers located mainly in Japan and the United States.
Financial Summary: BRIEF: For the nine months ended 31 December 2023, Takeda Pharmaceutical Co Ltd revenues increased 5% to Y3.213T. Net income applicable to common stockholders decreased 49% to Y147.08B. Revenues reflect Pharmaceutical Business segment increase of 6% to Y3.15T, Europe And Canada (Country) segment increase of 14% to Y721.54B, United States segment increase of 4% to Y1.685T.